斯達外科手術 STAA 深 滬
交易中 04-01 10:45:35 美东时间
19.07
+0.370
+1.98%
華盛通- 最 高19.07
- 今 開18.75
- 成交量 5.27万股
- 最 低 18.53
- 昨 收 18.70
- 總市值 9.44亿
- 52周最高 30.81
- 市盈率 靜 --
- 換手率 0.11%
- 52周最低 15.585
- 委 比 9.50%
- 總股本 4951.27万
- 歷史最高 163.08
- 量 比 0.44
- 振 幅 2.89%
- 歷史最低 4.48
- 每 手 1
- 風險率 4.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review
Alcon cancels $356 million LENSAR merger due to regulatory delays and FTC opposition, adding pressure on shares.
03-17 21:04
Broadwood Partners, L.P. acquires STAAR Surgical common shares
Broadwood Partners, L.P. acquires STAAR Surgical common shares Broadwood Partners, L.P. reported an acquisition of common shares of STAAR Surgical Company. The filing lists reporting owners including Broadwood Partners, L.P., Broadwood Capital Inc, and Neal C. Bradsher, Director and 10% Owner, along
03-14 08:00
美股大行评级 | 最高582美元！博通获多家机构上调目标价；GENI、Okta、Rigetti Computing、Veeva Systems、Wix.com遭多家机构下调目标价
今日重点评级关注：韦德布什：维持TScan Therapeutics"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持莱斯康制药"买入"评级，目标价从4美元升至6美元
03-06 11:58
美股大行评级 | 7家上调，3家下调！CrowdStrike绩后大行评级现分歧；罗斯百货、塔吉特、Viking获多家大行上调目标价
今日重点评级关注：古根海姆：维持Dianthus Therapeutics"买入"评级，目标价从100美元升至200美元；HC Wainwright & Co.：维持Amylyx Pharmaceuticals"买入"评级，目标价从28美元升至34美元
03-05 13:56
Stifel Maintains Hold on Staar Surgical, Lowers Price Target to $18
Stifel analyst Thomas Stephan maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $19 to $18.
03-04 21:30
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Can Fite Biopharma (AMEX:CANF) stock rose 17.6% to $5.88 during Wednes...
03-04 20:05
财报速睇 | 斯达外科手术2025财年Q4营收0.58亿美元，同比增长18.1%；归母净利润亏损0.18亿美元，同比亏损缩窄46.4%
华盛资讯3月4日讯，斯达外科手术公布2025财年Q4业绩，公司Q4营收0.58亿美元，同比增长18.1%，归母净利润亏损0.18亿美元，同比亏损缩窄46.4%。
03-04 05:49
STAAR Surgical shares are trading lower after the company reported worse-than-expected Q4 financial results.
STAAR Surgical shares are trading lower after the company reported worse-than-e...
03-04 05:25
Earnings Breakdown: Staar Surgical Q4
The earnings results for Staar Surgical (NASDAQ:STAA) for Q4 were made public o...
03-04 05:20
Staar Surgical Q4 Adj. EPS $(0.13) Misses $0.06 Estimate, Sales $57.801M Miss $75.370M Estimate
Staar Surgical (NASDAQ:STAA) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $0.06 by 328.07 percent. This is a 81.16 percent increase over losses of $(0.69) per share from
03-04 05:19
